Scientist Q&A Part 1: Samuel Yamin
After years of building evidence strategies with manufacturers, 3Aware Principal Clinical Scientist Samuel Yamin, MPH, has seen what holds… continue reading
Blog
Scientist Q&A Part 2: Samuel Yamin
In Part 1, Samuel broke down what actually matters when you’re trying to turn messy clinical RWD into evidence that holds up under scrutiny… continue reading
Post-Market Clinical Follow-up Case Study: Cook Medical
Background Medical device manufacturers–with the involvement of notified bodies–must declare compliance, for both new and established… continue reading
Introducing aiSurveillance™: Revolutionizing MedTech Surveillance with Real-World Evidence
In the evolving landscape of medical device real-world evidence (RWE), particularly under the rigorous demands of the EU Medical Device… continue reading